Announced Wed, 5 Nov · 13:21 IST

Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited financial ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Natural Biocon (India) Ltd has informed the BSE that its Board of Directors will meet on Wednesday, 12 November 2025, at the company's registered office. The key agenda item is the approval of the unaudited financial results for the half year ended 30 September 2025, along with the auditor's limited review report. Any other business may also be taken up with the chairman's permission. The intimation has been filed under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29) on 5 November 2025.

Likely market impact

This is a routine compliance filing ahead of the half-yearly results announcement. Investors should watch the actual results on or after 12 November for any signs of revenue or profitability changes, but nothing material is disclosed yet.